Ftse Mib
38.592,81
-0,48%
DAX
23.008,94
-1,87%
S&P 500
5.770,20
0,55%
NASDAQ
18.196,22
0,70%
Bitcoin
82.428,06
-4,33%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tiziana Life Sciences Ltd (TLSA) Tiziana Life Sciences Ltd (TLSA) Notizie

Tiziana Life Sciences Ltd

TLSA
1,7897
0,2897 (19,31%)
08 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/3/202514:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/3/202514:00GLOBETiziana Life Sciences Files Investigational New Drug..
27/2/202514:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/2/202514:00GLOBETiziana Life Sciences Announces Groundbreaking Study..
25/2/202514:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/2/202514:00GLOBETiziana Life Sciences Announces Long Covid Study to Complete..
21/2/202514:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/2/202514:00GLOBETiziana Life Sciences Announces Agreement for Product..
18/2/202514:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/2/202514:00GLOBETiziana Life Sciences Announces Dosing of Additional..
11/2/202515:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/2/202515:15GLOBETiziana Life Sciences Announces TV Interview with First..
31/1/202523:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202513:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202521:00GLOBETiziana Life Sciences Announces Positive Results in Treating..
23/1/202514:54GLOBETiziana Life Sciences not to engage in capital raising..
22/1/202522:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/1/202522:05GLOBETiziana Life Sciences Announces Discovery of New Immune..
10/1/202514:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202514:00GLOBETiziana Announces Reduction of Side Effects Commonly Seen..
08/1/202513:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202513:00GLOBETiziana Life Sciences Announces Review Article Published in..
17/12/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/12/202413:00GLOBETiziana Life Sciences Announces First Patient with Moderate..
04/12/202422:00APSThis Biotech Found Significant Success Following Key..
04/12/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/12/202413:00GLOBETiziana Life Sciences Expands Phase 2 Clinical Trial for..
19/11/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/11/202413:00GLOBETiziana Life Sciences Announces Groundbreaking ALS Trial..
01/11/202418:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202418:00GLOBETiziana Life Sciences to Participate in BIO-Europe 2024 to..
01/11/202411:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
31/10/202403:29GLOBETiziana Life Sciences Announces Registered Direct Offering..
30/10/202413:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202413:30GLOBETiziana Life Sciences Announces Positive Results from..
25/10/202423:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202423:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/10/202423:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/9/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/9/202413:00GLOBETiziana Life Sciences Announces $4 Million Grant Awarded by..
19/8/202414:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/8/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/8/202423:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/7/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/6/202414:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/6/202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/6/202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/5/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/5/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/5/202423:00EDGAR2Form 20-F - Annual and transition report of foreign private..
Apertura: 1,58 Min: 1,55 Max: 1,91
Chiusura: 1,50

La tua Cronologia

NASDAQ
TLSA
Tiziana Life Sciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci